Decorporation of Biohazards Utilizing Nanoscale Magnetic Carrier Systems

Nanofabrication Towards Biomedical Applications: Techniques, Tools, Applications, and Impact

Volumn , Issue , 2005, Pages 343-363

  Rosengart, Axel J ^a   Kaminski, Michael D ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

Biomedical applications; Decorporation of biohazards; Disclaimer; Microspheres; Nanoscale magnetic carrier systems; Nanospheres; Nanotechnology; Technological need

Indexed keywords

EID: 33947642163     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527603476.ch13     Document Type: Chapter

References (44)

1. S. S. Davis, Biomedical applications of nanotechnology - implications for drug targeting and gene therapy, Trends in Biotechnology 1997, 15, 217-224.
2. S. J. Douglas, S. S. Davis, L. Illum, Nanoparticles in drug delivery, CRC Critical Reviews in Therapeutic Drug Carrier Systems, 1987, 3, 233-261.
3. U. O. Häfeli, S. M. Sweeney, B. A. Beresford, E. H. Sim, R. M. Macklis, Magnetically directed poly(lactic acid) 90Y-microcapsules: novel agents for targeted intracavitary radiotherapy, Journal of Biomedical Materials Research, 1994, 28, 901-908.
4. A.S. Lübbe, C. Bergemann, W. Huhnt, T. Fricke, H. Riess, J. W. Brock, D. Huhn, Clinical experiences with magnetic drug targeting: a phase I study with 4¢-epidoxorubicin in 14 patients with advanced solid tumors, Cancer Research, 1996, 56, 4694-4701.
5. H. Yoshioka, Surface modification of haemoglobin-containing liposomes with polyethylene glycol prevents liposome aggregation in blood plasma, Biomaterials, 1991, 12, 861-864.
6. J.D. Slack, M. Kanke, G. H. Simmons, P. P. DeLuca, Acute hemodynamic effects and blood pool kinetics of polystyrene microspheres following intravenous administration, Journal of Pharmaceutical Sciences, 1981, 70, 660-664.
7. Y.-P. Li, Y. Y. Pei, X. Y. Zhang, Z. H. Gu, Z. H. Zhou, W. F. Yuan, J. J. Zhou, J. H. Zhu, X. J. Gao, PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats, Journal of Controlled Release, 2001, 71, 203-211.
8. R. Gref, Y. Minamitake, T. M. Peracchia, V. Trubetskoy, V. Torchilin, R. Langer, Biodegradable long-circulating polymeric nanospheres, Science, 1994, 263, 1600-1603.
9. S.K. Huang, E. Mayhew, S. Gilani, D. D. Lasic, F. J. Martin, D. Papahadjopoulos, Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoima, Cancer Research, 1992, 52, 6774-6781.
10. T. M. Allen, C. B.Hansen, D. E. L. Demenezes, Pharmacokinetics of long-circulating liposomes, Advanced Drug Delivery Reviews, 1995, 16, 267-284.
11. T. M. Allen, E. H. Moase, Therapeutic opportunities for targeted liposomal drug delivery, Advanced Drug Delivery Reviews, 1996, 21, 117-133.
12. S. E. Dunn, A. Brindley, S. S. Davis, M. C. Davies, L. Illum, Polystyrene-poly(ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution, Pharmaceutical Research, 1994, 11, 1016-1022.
13. T. Yamaoka, Y. Tabata, Y. Ikada, Comparison of body distribution of poly(vinyl alcohol) with other water-soluble polymers after intravenous administration, The Journal of Pharmacy and Pharmacology, 1995 47, 479.
14. R. Arshady and M. Monshipouri, Targeted delivery of microparticulate carriers, in R. Arshady (ed.) Microspheres microcapsules and liposomes, vol. 2, London, Citus Books, 1999, pp. 403-432.
15. U. O. Häfeli and G. J. Pauer, In vitro and in vivo toxicity of magnetic microspheres, Journal of Magnetism and Magnetic Materials, 1999, 194, 76-82.
16. B. Erbas, M. T. Ercan, B. Caner, Biodistribution and localization of radiolabeled microparticles, in R. Arshady (ed.) Microspheres Microcapsules and Liposomes Series, vol. 3, London, Citus Books, 2001, pp. 249-280.
17. E. Okon, D. Pouliquen, P. Okon, Z. V. Kovaleva, T. P. Stepanova, S. G. Lavit, B. N. Kudryavtsev, P. Jallet, Biodegradation of magnetite dextran nanoparticles in the rat - a histologic and biophysical study, Laboratory Investigation, 1994, 71, 895-903.
18. D. Pouliquen, J. J. Le Jeune, R. Perdrisot, A. Ermias, P. Jallet, Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism, Magnetic Resonance Imaging, 1991, 9, 275-283.
19. Z. Tang, H. T. Karnes, Heterogeneous postcolumn immunoreaction detection using magnetized beads and a laboratory-constructed electromagnetic separator, Biomedical Chromatography, 2003, 17, 118-125.
20. G. A. Martin-Henao, M. Picon, B. Amill, S. Querol, J. R. Gonzalez, C. Martinez, R. Martino, C. Ferra, S. Brunet, A. Granena, J. Sierra, J. Garcia, Isolation of CD34+ progenitor cells from peripheral blood by use of an automated immunomagnetic selection system: factors affecting the results, Transfusion, 2000, 40, 35-43.
21. M. Berger, J. Castelino, R. Huang, M. Shah, R. H. Austin, Design of a microfabricated magnetic cell separator, Electrophoresis, 2001, 22, 3883-3892.
22. L. Sun, M. Zborowski, L. R. Moore, J. J. Chalmers, Continuous, flow-through immunomagnetic cell sorting in a quadrupole field, Cytometry, 1998, 33, 469-475.
23. A. J. Richards, O. S. Roath, R. J. Smith, J. H. Watson, High purity, recovery, and selection of human blood cells with a novel high gradient magnetic separator, Journal of Hematotherapy, 1996, 5, 415-426.
24. M. Downbrow (ed.), Microcapsules and nanoparticles in medicine and pharmacy, Boca Raton, CRC Press, 1992.
25. R. Arshady (ed.), Microspheres, microcapsules, and liposomes, Vol. 1-3, London, Citus Books, 1999.
26. U. Edlund, A. C. Albertsson, Degradable polymer microsphere for controlled drug delivery, Advances in Polymer Science, 2002, 157, 67-112.
27. R. Gref, Surface-engineered nanoparticles as drug carriers, in M.-I. Baraton (ed.) Synthesis, functionalization and surface treatment of nanoparticles, Stevenson Ranch, CA, American Scientific Publishers, 2003, 234-257.
28. U. O. Hafeli, W. Schutt, J. Teller, and M. Zborowski, Scientific and clinical applications of magnetic carriers, New York, Plenum Press, 1997.
29. M. D. Kaminski, A. Ghebremeskel, L. Nunez, K. Kasza, F. Chang, T. Chien, P. Fischer, J. Eastman, A. J. Rosengart, R. L. McDonald, Y. Xie, L. M. Johns, P. Pytel, U. O. Hafeli, Magnetically responsive microparticles for targeted drug and radionuclide delivery: a review of recent progress and future challenges, Argonne National Laboratory Report ANL-03/28, 2003.
30. A. Brindley, M. C. Davies, R. A. P. Lynn, S. S. Davis, J. Hearn, J. F. Watts, The surface characterization of model charged and sterically stabilized polymer colloids by SSIMS and XPS, Polymer, 1992, 33, 1112-1115.
31. R. Duncan and J. Kopecek, Soluble synthetic polymers as potential drug carriers, Advances in Polymer Science, 1984, 57, 51-101.
32. S. N. J. Pang, Final report on the safety assessment of polyethylene glycols (PEGs)-6, -8, -32, -75, -150, 14M, -20M, Journal of the American College of Toxicology, 1993, 12, 429-457.
33. S. Dreborg, and E. B. Akerblom, Immunotherapy with monomethoxypolyethylene glycol modified allergens, Critical Reviews in Therapeutic Drug Carrier Systems, 1990, 6, 315-365.
34. J. Harris, Laboratory synthesis of polyethylene glycol derivatives, Journal of Macromolecular Science, Part C - Reviews in Macromolecular Chemistry and Physics, 1985, C25, 325-373.
35. S. I. Jeon and J. D. Andrade, Protein-surface interactions in the presence of polyethylene oxide: II. Effect of protein size, Journal of Colloid and Interface Science, 1991, 142, 159-166.
36. V. P. Torchilin and V. S. Trubetskoy, Which polymers can make nanoparticulate drug carriers long-circulating?, Advanced Drug Delivery Reviews, 1995, 16, 141-155.
37. V. P. Torchilin, V. G. Omelyanenko, M. I. Papisov, A. A. Bogbanov Jr., V. S. Trubetskoy, J. N. Herron, C. A. Gentry, Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity, Biochimica et Biophysica Acta, 1994, 1195, 11-20.
38. I. Szleifer, Protein adsorption on surfaces with grafted polymers: a theoretical approach, Biophysical Journal, 1997, 72, 595-612.
39. T. M. Allen, C. Hansen, F. Martin, C. Redemann, A. Yau-Young, Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo, Biochimica et Biophysica Acta, 1991, 1066, 29-36.
40. R. Gref, A. Domb, P. Quellec, T. Blunk, R. H. Muller, J. M. Verbavatz, R. Langer, The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres, Advanced Drug Delivery Reviews, 1995, 16, 215-233.
41. V. C. F. Mosqueira, P. Legrand, J. L. Morgat, M. Vert, E. Mysiakine, R. Gref, J. P. Devissaguet, G. Barratt, Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density, Pharmaceutical Research, 2001, 18, 1411-1419.
42. A. K. Salem, S. M. Cannizzaro, M. C. Davies, S. J. B. Tendler, C. J. Roberts, P. M. Williams, K. M. Shakesheff, Synthesis and characterization of a degradable poly(lactic acid)-poly(ethylene glycol) copolymer with biotinylated end groups, Biomacromolecules, 2001, 2, 575-580.
43. C. J. Mertz, M. D. Kaminski, Y. Xie, M. R. Finck, S. G. Guy, A.J. Rosengart, In vitro studies of functionalized magnetic nanospheres for selective removal of a simulant biotoxin, Journal of Magnetism and Magnetic Materials, accepted August 2004.
44. H. S. Sakhalkar, M. K. Dalal, A. K. Salem, R. Ansari, J. Fu, M. F. Kiani, D. T. Kurjiaka, J. Hanes, K. M. Shakesheff, D. J. Goetz, Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo, Proceedings of the National Academy of Scinces of the United States of America, 2003, 100, 15895-15900.